74 related articles for article (PubMed ID: 25521742)
21. [Experimental study of the hepatocyte growth factor contributing to lymphangiogenesis and lymphatic metastasis in gastric cancer].
Zhang QH; Qian K; Li XJ; Pu J; Wu XT
Zhonghua Wei Chang Wai Ke Za Zhi; 2007 May; 10(3):212-6. PubMed ID: 17520376
[TBL] [Abstract][Full Text] [Related]
22. [The expression of VEGF-C, VEGFR-3 and its predictive value on lymph node metastasis and prognosis of gastric cancer].
Han FH; Zhan WH; He YL; Li YM; Zheng ZQ; Peng JS; Cai SR; Ma JP
Zhonghua Wai Ke Za Zhi; 2006 Aug; 44(15):1058-61. PubMed ID: 17074247
[TBL] [Abstract][Full Text] [Related]
23. Vascular endothelial growth factor-D and its receptor VEGFR-3: two novel independent prognostic markers in gastric adenocarcinoma.
Jüttner S; Wissmann C; Jöns T; Vieth M; Hertel J; Gretschel S; Schlag PM; Kemmner W; Höcker M
J Clin Oncol; 2006 Jan; 24(2):228-40. PubMed ID: 16344322
[TBL] [Abstract][Full Text] [Related]
24. Effects of rosiglitazone on the growth and lymphangiogenesis of human gastric cancer transplanted in nude mice.
Chen FZ; Mo XM; Wang QP; Li J; Zhang L
Oncol Rep; 2013 Dec; 30(6):2705-12. PubMed ID: 24002492
[TBL] [Abstract][Full Text] [Related]
25. [Correlation of lymphangiogenesis to progression of colorectal cancer].
Wang TB; Huang YH; Lan P; Song XM; Wang JP
Ai Zheng; 2005 Oct; 24(10):1276-9. PubMed ID: 16219148
[TBL] [Abstract][Full Text] [Related]
26. Lymphangiogenesis and angiogenesis in bladder cancer: prognostic implications and regulation by vascular endothelial growth factors-A, -C, and -D.
Miyata Y; Kanda S; Ohba K; Nomata K; Hayashida Y; Eguchi J; Hayashi T; Kanetake H
Clin Cancer Res; 2006 Feb; 12(3 Pt 1):800-6. PubMed ID: 16467091
[TBL] [Abstract][Full Text] [Related]
27. Peritumoral lymphatic vessel density and vascular endothelial growth factor C expression in early-stage squamous cell carcinoma of the uterine cervix.
Gombos Z; Xu X; Chu CS; Zhang PJ; Acs G
Clin Cancer Res; 2005 Dec; 11(23):8364-71. PubMed ID: 16322297
[TBL] [Abstract][Full Text] [Related]
28. Does a growing tumour volume induce lymphangiogenesis? A study of oral/oropharyngeal cancer.
Chung EJ; Rho YS; Baek SK; Woo JS; Kwon SY; Lee NJ; Chae YS; Jung KY
J Otolaryngol Head Neck Surg; 2011 Aug; 40(4):311-7. PubMed ID: 21777549
[TBL] [Abstract][Full Text] [Related]
29. Vascular endothelial growth factor-D induces lymphangiogenesis and lymphatic metastasis in models of ductal pancreatic cancer.
Von Marschall Z; Scholz A; Stacker SA; Achen MG; Jackson DG; Alves F; Schirner M; Haberey M; Thierauch KH; Wiedenmann B; Rosewicz S
Int J Oncol; 2005 Sep; 27(3):669-79. PubMed ID: 16077915
[TBL] [Abstract][Full Text] [Related]
30. Role of lymphangiogenesis and lymphangiogenic factors during pancreatic cancer progression and lymphatic spread.
Schneider M; Büchler P; Giese N; Giese T; Wilting J; Büchler MW; Friess H
Int J Oncol; 2006 Apr; 28(4):883-90. PubMed ID: 16525637
[TBL] [Abstract][Full Text] [Related]
31. The tyrosine kinase inhibitor cediranib blocks ligand-induced vascular endothelial growth factor receptor-3 activity and lymphangiogenesis.
Heckman CA; Holopainen T; Wirzenius M; Keskitalo S; Jeltsch M; Ylä-Herttuala S; Wedge SR; Jürgensmeier JM; Alitalo K
Cancer Res; 2008 Jun; 68(12):4754-62. PubMed ID: 18559522
[TBL] [Abstract][Full Text] [Related]
32. Molecular control of lymphatic metastasis.
Achen MG; Stacker SA
Ann N Y Acad Sci; 2008; 1131():225-34. PubMed ID: 18519975
[TBL] [Abstract][Full Text] [Related]
33. High lymphatic vessel density correlates with overexpression of VEGF-C in gastric cancer.
Hachisuka T; Narikiyo M; Yamada Y; Ishikawa H; Ueno M; Uchida H; Yoriki R; Ohigashi Y; Miki K; Tamaki H; Mizuno T; Nakajima Y
Oncol Rep; 2005 Apr; 13(4):733-7. PubMed ID: 15756450
[TBL] [Abstract][Full Text] [Related]
34. VEGF-D in association with VEGFR-3 promotes nodal metastasis in human invasive lobular breast cancer.
van Iterson V; Leidenius M; von Smitten K; Bono P; Heikkilä P
Am J Clin Pathol; 2007 Nov; 128(5):759-66. PubMed ID: 17951197
[TBL] [Abstract][Full Text] [Related]
35. Detection of lymphatic invasion in early stage primary colorectal cancer with the monoclonal antibody D2-40.
Walgenbach-Bruenagel G; Tolba RH; Varnai AD; Bollmann M; Hirner A; Walgenbach KJ
Eur Surg Res; 2006; 38(5):438-44. PubMed ID: 16912482
[TBL] [Abstract][Full Text] [Related]
36. Clinical significance of vascular endothelial growth factor-C and vascular endothelial growth factor receptor 3 in patients with T1 lung adenocarcinoma.
Kojima H; Shijubo N; Yamada G; Ichimiya S; Abe S; Satoh M; Sato N
Cancer; 2005 Oct; 104(8):1668-77. PubMed ID: 16116610
[TBL] [Abstract][Full Text] [Related]
37. Complete and specific inhibition of adult lymphatic regeneration by a novel VEGFR-3 neutralizing antibody.
Pytowski B; Goldman J; Persaud K; Wu Y; Witte L; Hicklin DJ; Skobe M; Boardman KC; Swartz MA
J Natl Cancer Inst; 2005 Jan; 97(1):14-21. PubMed ID: 15632376
[TBL] [Abstract][Full Text] [Related]
38. Lymphangiogenesis in gastric carcinoma correlates with prognosis.
Gao P; Zhou GY; Zhang QH; Su ZX; Zhang TG; Xiang L; Wang Y; Zhang SL; Mu K
J Pathol; 2009 Jun; 218(2):192-200. PubMed ID: 19224540
[TBL] [Abstract][Full Text] [Related]
39. Expression of vascular endothelial growth factor-C in gastric carcinoma and the effect of its antisense gene transfection on the proliferation of human gastric cancer cell line SGC-7901.
Zhu P; Zhang J; Chen Q; Wang J; Wang Y
Am J Surg; 2012 Jul; 204(1):78-83. PubMed ID: 22227171
[TBL] [Abstract][Full Text] [Related]
40. Semaphorin 4D expression is associated with a poor clinical outcome in cervical cancer patients.
Liu H; Yang Y; Xiao J; Yang S; Liu Y; Kang W; Li X; Zhang F
Microvasc Res; 2014 May; 93():1-8. PubMed ID: 24603190
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]